MedTrace Logo

Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil

NCT06014580 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 276

Last updated 2025-03-07

No results posted yet for this study

Summary

An evaluation of the molecular and epidemiological aspects of endometrial cancer in Brazil is necessary to understand the high frequency of advanced disease. A better understanding of the current situation will generate essential data for the future development of national or international cooperative programs that aim to improve outcomes in these patients and generate additional knowledge for much-needed clinical trials in this population.

Conditions

Interventions

OTHER

Observational study

This is an observational study; patients will not be exposed to clinical interventions different from those belonging to the standard of care.

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Latin American Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Andreia Cristina de Melo · Latin American Cooperative Oncology Group

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-27
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06014580 on ClinicalTrials.gov